Page 135 - Prostate News Today

New approach can advance medical AI algorithms, reduce risks to patient privacy Within the field of artificial intelligence (AI), deep learning is an area of rapid and high-impact innovation in the healthcare industry. Being able to successfully train computers to perform medical tasks has extraordinary potential to improve patient care, increase access, and reduce costs. Researchers at UCLA have already developed AI systems that have had significant value in helping physicians more accurately ...

New prostate cancer fitness class first in northern NZ A new specialist fitness class for men living with prostate cancer has been started in Stanmore Bay on Whangaparāoa Peninsula. The Prost-FIT exercise group is one of only seven such classes throughout New Zealand and is the only one being held anywhere north of Auckland’s North Shore. Group trainer Lis MacLeod says research shows that exercise can increase cancer survival rates by as much as 60 percent and the classes will benefit men at...

Bottom Line: Cancer survivors had a greater risk of reduced ambulatory function, which was associated with an increased risk of death.

Scientists test the effect of natural product isolated from sea sponge on cancer cells Scientists from Far Eastern Federal University (FEFU) together with Russian and German colleagues, continue studying antitumor compounds synthesized based on bioactive molecules isolated from a sea sponge. One of them fights cancer cells resistant to standard chemotherapy, and at the same time has an interesting dual mechanism of action. A related article appears in Marine Drugs. Scientists have tested the b...

Photo Credit: IANS IANSLive New York, Feb 21 (IANS) There is a possibility that targeting the enzyme MAPK4 in human prostate cancer might provide a novel therapeutic strategy for the disease, said researchers. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 21-Fe...

The study indicates that the enzyme MAPK4 concertedly activates androgen receptor (AR) and AKT, molecules at the core of two cellular signalling pathways known to promote prostate cancer growth and resistance to standard therapy.

The study indicates that the enzyme MAPK4 concertedly activates androgen receptor (AR) and AKT, molecules at the core of two cellular signalling pathways known to promote prostate cancer growth and resistance to standard therapy.

Targeting MAPK4 enzyme may be a potential new strategy to combat prostate cancer The battle against late-stage prostate cancer might have found a potential new strategy to combat this deadly disease. Research led by Baylor College of Medicine reveals in the Journal of Clinical Investigation that the enzyme MAPK4 concertedly activates androgen receptor (AR) and AKT, molecules at the core of two cellular signaling pathways known to promote prostate cancer growth and resistance to standard therap...

About 20% of people have high levels of lipoprotein(a), or Lp(a), a fatty particle linked to premature heart disease. People who should consider getting an…

Eating foods such as red meat and sugary treats may trigger inflammation, raising a person’s risk of cardiovascular disease. But a diet rich in fruits,…